Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZVS203e in Retinitis Pigmentosa Associated With RHO Mutation
NCT06952842Phase 2Recruiting
- Sponsor
- CHIGENOVO
- Start
- Aug 2025
- Primary completion
- Jun 2030
- Modality
- Gene Editing, Gene Silencing, Gene Addition/Replacement
- Countries
- 1
01
Overview
A Phase 2 trial of ZVS203e in retinitis pigmentosa (RP), sponsored by CHIGENOVO. Started Aug 2025; status: recruiting.
02
Drugs
ZVS203e
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT06952842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06952842.